Order results by:
Issue | Title | |
Vol 12, No 2 (2019) | Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers | Abstract similar documents |
E. V. Radchenko, A. S. Kolbin | ||
"... , the burden of tobacco smoking (including the direct costs of medical care and payment for temporary ..." | ||
Vol 6, No 4 (2013) | Using indirect comparisons in pharmacoeconomic examination | Abstract similar documents |
Yu. E. Balykina, A. S. Kolbin | ||
"... Health technology assessment is a fundamental tool while choosing the most cost- and clinical ..." | ||
Vol 7, No 1 (2014) | ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY | Abstract similar documents |
T. L. Galankin, A. S. Kolbin | ||
"... использование очень большой выборки, включающей все возможные группы пациентов в исследуемой популяции. В статье ..." | ||
Vol 7, No 3 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA | Abstract similar documents |
A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova | ||
"... . Pharmacoeconomic analysis of application of oxaliplatin in colorectal cancer was performed. Cost-effectiveness ..." | ||
Vol 7, No 2 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin | ||
"... is economically expedient from the point of view of a ratio of cost and efficiency. ..." | ||
Vol 10, No 1 (2017) | PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS | Abstract similar documents |
A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina | ||
"... -guaranteed free medical care will not increase the costs of the treatment in patients with relapsed ..." | ||
Vol 11, No 1 (2018) | CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation | Abstract similar documents |
A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin | ||
"... decision-making model was created. The model calculates direct medical costs for the patient care ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract similar documents |
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
"... . This study estimated the cost of illness, probability of development different events in varied strategy ..." | ||
Vol 9, No 3 (2016) | HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE | Abstract similar documents |
A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina | ||
"... conditions. Markov modelling and CEA accounting for direct medical costs were used. The effectiveness ..." | ||
Vol 8, No 1 (2015) | BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
"... первой линии терапии множественной миеломы у пациентов старше 65 лет, которым не показана аутологичная ..." | ||
Vol 6, No 2 (2013) | FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS | Abstract similar documents |
A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure | ||
"... .). Cost-effectiveness analysis was performed. Results: The developed model allows to assess the risk ..." | ||
Vol 10, No 2 (2017) | ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) | Abstract similar documents |
Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel’, A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina | ||
"... approved for national clinical practice. Aim. To perform a cost-effectiveness analysis of the commonly ..." | ||
Vol 11, No 1 (2018) | Modeling microbial drug-resistance: from mathematics to pharmacoeconomics | Abstract similar documents |
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko | ||
"... experience with antimicrobial drugs, we calculated the cost of treatment of complicated IAI when either ..." | ||
1 - 13 of 13 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)